Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivastigmine in Postoperative Delirium
NCT00835159Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Dec 2008
- Primary completion
- Jul 2010
- Modality
- Reversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of rivastigmine in postoperative delirium (POD), Post-operative cognitive dysfunction (POCD), sponsored by NYU Langone Health. Started Dec 2008; status: completed.
02
Drugs
rivastigmine
03
Conditions
postoperative delirium (POD)Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT00835159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00835159.